virologic

Related by string. ViroLogic * * sustained virologic response . virologic suppression . virologic response EVR . virologic failure . rapid virologic response . virologic response . Sustained Virologic Response . Sustained virologic response . experienced virologic failure . achieved sustained virologic . achieve sustained virologic . virologic responses . virologic breakthrough *

Related by context. Frequent words. (Click for all words.) 68 virological 66 sustained virologic response 65 peginterferon 65 peginterferon alfa 2a 64 seroconversion 64 raltegravir 64 lamivudine 64 viral suppression 63 vicriviroc 63 sunitinib 62 adalimumab 62 plus ribavirin 62 adefovir 62 HCV infected 62 antiviral activity 62 undetectable viral load 62 viral load 62 HAART 61 dasatinib 61 NRTIs 61 evaluable patients 61 bosentan 61 antiviral therapy 61 entecavir 61 HCV genotype 1 61 imatinib 61 darunavir 61 Phase 2a trial 60 NNRTI 60 HCV RNA 60 bevirimat 60 TMC# [001] 60 pegylated interferon 60 imetelstat 60 etanercept 60 antibody responses 60 tiotropium 60 clinically meaningful 60 genotypic 59 azacitidine 59 CYT# 59 temsirolimus 59 linezolid 59 Pharmacokinetic 59 viral loads 59 log# 59 gefitinib 59 antitumor activity 59 ISENTRESS 59 sitagliptin 59 infliximab 59 mg BID 58 evaluable 58 rituximab 58 median PFS 58 trastuzumab 58 topotecan 58 titers 58 PXD# 58 bortezomib 58 Taxotere ® 58 CA4P 58 HbA1c levels 58 copies ml 58 free survival PFS 58 cetuximab 57 pharmacodynamic 57 serological 57 nilotinib 57 antiretroviral therapy 57 RECIST criteria 57 tolerability 57 statistically significant p 57 limiting toxicity 57 mcg kg 57 moxifloxacin 57 monotherapy 57 docetaxel 57 mitoxantrone 57 ribavirin 57 atazanavir 57 chronic HCV infection 57 teriparatide 57 zoledronic acid 57 plasma concentrations 57 TORISEL 57 neutralizing antibodies 57 telbivudine 57 adjuvant therapy 56 FOLFOX 56 HGS ETR1 56 abacavir 56 HBV infection 56 ceftriaxone 56 GRN#L 56 Secondary endpoints 56 disease progression 56 HbA1c 56 copies mL 56 mg dose 56 dosing regimens

Back to home page